Stay updated on XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial

Sign up to get notified when there's something new on the XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A government funding notice banner was added, and the site revision tag was updated from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T10:13:31.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option and updated some metadata labels (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data') along with a new revision note 'Revision: v3.4.0'; the previous labels ('Last Update Submitted that met QC Criteria' and 'No FEAR Act data') and prior revision note 'Revision: v3.3.4' were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T05:00:46.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page now lists Revision: v3.3.4 and no longer shows Revision: v3.3.3.
    Difference
    0.1%
    Check dated 2026-01-14T01:43:21.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Added a Locations section with Massachusetts as a study site and updated the page revision to v3.3.3. Removed HHS Vulnerability Disclosure and several related topics (including MedlinePlus Genetics and Massachusetts Locations) from the page.
    Difference
    0.4%
    Check dated 2025-12-23T08:57:04.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Added Prostate cancer and related topics: MedlinePlus Genetics to the study page to improve context and navigation.
    Difference
    0.2%
    Check dated 2025-12-16T02:55:16.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Prostate cancer and related topics: MedlinePlus Genetics have been removed from the page.
    Difference
    0.2%
    Check dated 2025-12-09T00:29:24.000Z thumbnail image

Stay in the know with updates to XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial page.